Has Maryyam Ali, MD received payments from drug or device companies?

Yes. Drug and device makers reported $241 in general payments to Maryyam Ali, MD across 8 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Maryyam Ali, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Maryyam Ali, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Maryyam Ali, MD

Nephrology · Maplewood, MNNPI 1518386093

Payments from drug & device makers

$241in general payments, 2019–2025

Across 8 payments — averaging $30.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bard Peripheral Vascular, Inc.$120
Ardelyx, Inc.$34
Travere Therapeutics, Inc.$34
Otsuka America Pharmaceutical, Inc.$25
Aurinia Pharma U.S., Inc.$14
Novo Nordisk$13

What the payments were for

Food & beverage$241100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bard Peripheral Vascular, Inc.	1	$120
Ardelyx, Inc.	2	$34
Travere Therapeutics, Inc.	2	$34
Otsuka America Pharmaceutical, Inc.	1	$25
Aurinia Pharma U.S., Inc.	1	$14
Novo Nordisk	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

WAVELINQ$120

How this compares

$241 in reported general payments places this provider in the 55th percentile of 208 nephrology providers in Minnesota.

See all nephrology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$178,391

Medicare patients

212

Services billed

2,789

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XphozahTenapanor Hcl	19	$54,934
EntrestoSacubitril/Valsartan	43	$45,742
JardianceEmpagliflozin	50	$43,555
FarxigaDapagliflozin Propanediol	43	$39,136
Lanthanum Carbonate	32	$37,880
Sevelamer Carbonate	82	$20,622
Calcium Acetate	70	$8,254
LokelmaSodium Zirconium Cyclosilicate	12	$7,968
ProsolParenteral Amino Acid 20% No.1	49	$7,817
Torsemide	200	$6,232
Bumetanide	34	$4,185
Losartan Potassium	199	$3,713
Midodrine Hcl	60	$3,129
Carvedilol	191	$2,387
Cinacalcet Hcl	23	$1,840

Paid to pharmacies, not to this prescriber.

Other nephrology in Maplewood

Mark MatsonSt. Paul$6.3M
Daniel RiesBrooklyn Center$4.4M
Jonathan TolinsEdina$3.3M
John LieskeRochester$2.4M
George CanasBrooklyn Center$2.1M
Suzanne SwanMinneapolis$2.1M
Fernando FervenzaRochester$1.7M
Nattawat KlomjitRochester$1.5M
Neera DahlRochester$1.4M
Vicente TorresRochester$661K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →